Drug
GSK4532990
GSK4532990 is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
100%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
3(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting1
Completed1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (100.0%)
Trials by Status
recruiting133%
completed133%
active_not_recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698
active_not_recruitingphase_2
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344
completedphase_2
Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH
NCT06104319
Clinical Trials (3)
Showing 3 of 3 trials
NCT06613698Phase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT05583344Phase 2
Phase 2b Study of GSK4532990 in Adults With NASH
NCT06104319Phase 2
Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3